公司简介

中國抗體製藥有限公司

SinoMab Bioscience Limited (SinoMab) is a private company established in 2001 by a team of antibody and biotechnology professionals. It is a clinical stage biopharmaceutical company that creates and develops therapeutic antibodies. SinoMab has obtained three Investigational New Drug (IND) approval from China FDA for developing one of its lead products for non-Hodgkin’s Lymphoma (NHL) (淋巴癌), systemic lupus erythematosus (SLE) (紅斑狼瘡) and rheumatoid arthritis (RA) (類風濕關節炎).

+852 3426 9833
Dr. Shawn Leung

以上资料仅供参考。有关园区公司的最新资讯,请以其官方公布的讯息为准。

联系我们

如有一般咨询,或有关香港科技园服务与援助计划的问题,请在下方空白处填写您的电子邮箱和咨询内容。